Quanergy LiDAR Solutions to Accelerate the Adoption of Automation in the Material Handling Market
New M1 Edge™ offers 3x price/performance advantage vs. incumbent solutions for advanced navigation applications Quanergy…
Month: March 2022
Platform.sh commits to helping its customers reduce carbon emissions from cloud activities
Paris/San Francisco, 17th March 2022 – Platform.sh, a unified, secure, enterprise-grade platform for building, running…
Mainz Biomed Appoints Key Clinical Trial Partners for ColoFuture Study
Cutting Edge IVD Developer Sentinel Chosen to Provide Automated FIT Analysis System Leading Clinical Research…
Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer
Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer Study…
New Investment Platform from Bitlocus – Onboarding FIAT Users onto the Decentralized Finance World
Vilnius, Lithuania–(Newsfile Corp. – March 17, 2022) – Bitlocus, a global financial technology company, has…
Chinu (CHINU) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – March 17, 2022) – LBank Exchange, a global digital asset…
LBank Exchange Will List GogolCoin (GOL) on March 18, 2022
Internet City, Dubai–(Newsfile Corp. – March 17, 2022) – LBank Exchange, a global digital asset…
Oktacom Inc. Is Granted the 214 International Telecommunication License
Vancouver, British Columbia–(Newsfile Corp. – March 17, 2022) – Upco International Inc. (CSE: UPCO) (OTC…
Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement
Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to…
Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update
SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company…
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Total 2021 Revenues Increased Approximately 18% YoY to $141 Million Strong 2022 Revenue Growth Expected,…
Acumen Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on March 28, 2022
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 16, 2022 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ:…
Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Announces Strategic Pivot to Focus on Cell Therapy Programs Receives FDA Clearance for IND to…
Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer
Seasoned life sciences executive adds extensive global sales expertise to drive commercial efforts REDWOOD CITY,…
Synthetic Biologics Reports 2021 Year End Operational Highlights and Financial Results
-Completed acquisition of VCN Biosciences, expanding pipeline into oncology- -VCN-01 received Orphan Drug Designation for…
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
Utpal Koppikar C4 Therapeutics Appoints Utpal Koppikar to Board of Directors – Utpal Koppikar, Veteran…
Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum
TUSTIN, Calif., March 16, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics…
Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022
EMERYVILLE, Calif., March 16, 2022 (GLOBE NEWSWIRE) — Zymergen Inc. (“Zymergen” or the “Company”) today…
Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results
Fourth Quarter 2021 Revenue of $6.1 million Fourth Quarter 2021 Net Income of $1.0 million…
eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
SAN DIEGO and REDWOOD CITY, Calif., March 16, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc….